MAPT and Alzheimer disease: Considering that the eye is structurally less complex and more accessible than the brain, the current observation features the retina and vitreous humor—which can provide indirect information on retinal microenvironment [92, 126]—as reliable sources of clinically-predictive, tau-based ocular biomarkers of AD cerebral neurodegeneration.